SRK Capital has launched its 2026 Semi-Annual Partnership Letter, providing insights into the efficiency of its portfolio holdings and strategic funding choices. The replace highlights important progress in key firms like ImmuCell Company and Out of doors Holding Firm, alongside a profitable exit from Sanuwave Well being and the addition of Professional-Dex Inc. as a brand new funding. The agency’s industrial and manufacturing basket additionally demonstrated sturdy efficiency.
ImmuCell Company (ICCC) Reveals Robust Earnings Energy
ImmuCell Company delivered a sturdy first quarter in 2026, demonstrating the earnings functionality and cash-flow potential of its core First Protection product line. This efficiency follows the corporate’s strategic determination to exit the Re-Tain enterprise. Product gross sales noticed a considerable year-over-year improve of 28.4%, reaching $10.4 million. This development was attributed to elevated gross sales volumes, favorable pricing, and an estimated three-percentage-point acquire in market share inside the U.S. scours biologicals market.
The corporate’s gross margin expanded to 45.0%, a results of improved working leverage from elevated manufacturing. Internet earnings rose by 34% to $1.9 million. Regardless of latest inventory appreciation, ImmuCell is considered as a compelling funding alternative. Administration is actively repurposing the previous Re-Tain facility to spice up First Protection manufacturing capability past the present 450,000 models per 30 days. This enlargement is projected to help gross sales starting from $35 million to $40 million over the following 12 to 24 months. With gross margins round 45% and the removing of the Re-Tain growth prices, ImmuCell anticipates its annual EBITDA may develop to between $12 million and $14 million. That is anticipated to translate into free money move with minimal company tax implications for a number of years, owing to substantial web working loss carryforwards.
Out of doors Holding Firm (POWW) Reinforces Turnaround Thesis
Out of doors Holding Firm’s fiscal yr 2026 outcomes, encompassing each the fourth quarter and the complete yr, have bolstered the corporate’s core turnaround narrative. Since divesting its capital-intensive ammunition manufacturing operations in April 2025, the corporate has operated as an asset-light market primarily by way of GunBroker.com.
For the complete fiscal yr 2026, income elevated by 3.5% year-over-year to $51.1 million. Adjusted EBITDA noticed a major rise of 46%, reaching $22.3 million in comparison with $15.3 million within the earlier yr. This enchancment displays efficient price administration and enhanced platform monetization. The corporate’s momentum accelerated within the fourth quarter, with web income rising 10.1% year-over-year to $13.9 million. This was supported by an 11.8% improve in gross merchandise worth (GMV), which reached roughly $229 million. Gross margins remained exceptionally excessive at 87.6%. Moreover, decreased working bills contributed to a 163% surge in adjusted EBITDA, which climbed to $7.7 million from $2.9 million within the prior-year interval.
GunBroker.com demonstrated resilience even inside a subdued firearms market. Firearm unit gross sales on the platform grew 8.7% year-over-year throughout the quarter, considerably outperforming the 1.6% improve in adjusted NICS background checks. The adjusted EBITDA run charges noticed over the previous three quarters have persistently surpassed administration’s goal of $25 million, reaching this milestone nicely forward of the August 2025 projection.
The corporate maintains a powerful steadiness sheet, with $68.1 million in money and equivalents on the shut of the fiscal yr. Out of doors Holding Firm additionally initiated a capital return program by way of a $15 million share repurchase initiative, buying 513,925 shares for about $1.0 million at a mean value of $1.95 per share.
Present strategic focuses embody platform enhancements geared toward driving GMV development and rising the take charge. Key initiatives accomplished throughout the fiscal yr embody the mixing of MasterFFL to streamline vendor verification for over 32,000 licensed sellers and the launch of an AI-powered itemizing device designed to enhance product descriptions and conversion charges. For fiscal yr 2027, the implementation of common cost processing is predicted to allow particular person sellers to simply accept bank cards immediately by way of the platform’s checkout. This characteristic addresses the roughly 30% of platform quantity presently processed manually and is anticipated to create a brand new, high-margin income stream. With potential for modest take-rate enlargement, a potential cyclical restoration in firearms demand previous the 2028 election cycle, excessive gross margins, a web money place, and energetic share buybacks, Out of doors Holding Firm is seen as having a viable path to realize $35 million to $40 million in EBITDA over the following 18 to 24 months, positioning it as a beautiful funding.
Industrial & Manufacturing Basket Sees Vital Good points
The commercial and manufacturing phase of the portfolio carried out exceptionally nicely within the first half of 2026, with common holdings appreciating by over 50% year-to-date on a consolidated foundation. The funding thesis for these micro-cap industrial firms centered on a transparent inflection level, difficult the market’s notion of them as purely commoditized or extremely cyclical. These companies had navigated a two-year interval marked by important post-pandemic stock destocking, elevated enter prices, and depressed operational utilization, whereas sustaining robust area of interest market positions, sturdy steadiness sheets, and appreciable working leverage.
The basic outcomes from this group have validated this outlook. As buyer stock ranges normalized and provide chain disruptions eased, even a modest restoration in gross sales volumes started to positively influence earnings. Many administration groups had proactively decreased price constructions, consolidated amenities, and eradicated legacy overhead throughout the downturn. This strategic resizing has enabled baseline quantity restoration to drive substantial enhancements in gross margins and working money move.
An illustrative instance is a specialised artificial fiber and supplies producer acquired at a major low cost to its tangible e-book worth. This firm had confronted strain from an prolonged destocking cycle throughout the worldwide textile and attire provide chain, resulting in income declines and extreme margin compression. As an alternative of passively awaiting demand restoration, its administration executed a complete operational turnaround. This concerned closing redundant vegetation, relocating manufacturing to cheaper areas, and specializing in proprietary, higher-margin merchandise. As order volumes stabilized, the corporate’s inherent working leverage grew to become obvious. The enterprise transitioned from working losses to money era, gross margins recovered by a number of hundred foundation factors, and the inventory valuation subsequently improved.
Capital allocation throughout this basket has remained disciplined. Bolstered by net-cash or low-leverage steadiness sheets, a number of administration groups have utilized extra money move to repurchase undervalued shares, thereby enhancing per-share worth. Regardless of the basket’s robust year-to-date efficiency, these firms proceed to commerce at modest multiples relative to their normalized earnings and free money move. As demand of their core finish markets continues to get better, SRK Capital believes this group is within the early phases of a multi-year earnings restoration cycle.
Sanuwave Well being, Inc. (SNWV) Place Absolutely Exited
SRK Capital has absolutely exited its place in Sanuwave Well being, Inc. throughout the first half of 2026. The corporate was a comparatively small holding at the beginning of the yr. The preliminary funding was made when Sanuwave traded at a deep low cost on the OTC market, and the fund realized most of its beneficial properties by promoting the vast majority of its stake at considerably larger costs within the $20s and $30s.
The choice to promote the remaining shares was prompted by a evaluate of the corporate’s first-quarter outcomes, which decreased visibility into future development prospects. A lot of Sanuwave’s latest income development had been pushed by cell wound-care clinics using the UltraMist platform. Nevertheless, the financial panorama for these operators shifted considerably. Beforehand, cell clinics loved excessive margins from tissue-based pores and skin grafts. Whereas UltraMist presents medical advantages, its reimbursement profile is just not as favorable. Lowered reimbursement charges led to margin compression for these clinics, putting many underneath appreciable monetary pressure. SRK Capital’s evaluation indicated {that a} substantial portion of this buyer base was, and sure stays, financially weak.
On condition that Sanuwave’s ahead development was closely reliant on this structurally challenged channel, the risk-reward profile had deteriorated. Though Sanuwave finally proved to be a profitable funding for the fund, the exit from the remaining place permits for the redeployment of capital into alternatives with better predictability and sturdiness of future money flows.
New Holding: Professional-Dex Inc. (PDEX)
Professional-Dex Inc. represents a brand new addition to the portfolio, with shares acquired throughout the fourth quarter of the earlier yr. The agency had adopted Professional-Dex for a few years, looking for an opportune entry level at a beautiful valuation. This chance arose when the inventory value declined attributable to issues in regards to the potential non-renewal of Professional-Dex’s largest buyer contract on the finish of 2025. These issues had been alleviated when the corporate secured a three-year contract extension by way of 2028, which incorporates minimal buy commitments for 2026 and 2027. This renewal underscores the longevity of a relationship spanning over fifteen years and gives a steady, cash-generative basis for Professional-Dex’s development initiatives.
Professional-Dex operates as a specialised medical machine producer, designing, constructing, and repairing powered surgical handpieces for main authentic gear producers (OEMs) underneath long-term, unique provide agreements. These relationships are inherently troublesome to disrupt attributable to customer-specific regulatory clearances, validated manufacturing processes, mental property, and distinctive designs related to every product.
A major development driver for Professional-Dex is its function because the unique {hardware} and element companion for Zimmer Biomet’s mBôs robotic surgical procedure platform. Professional-Dex manufactures the platform’s motorized end-effector elements and earns a high-margin sourced product price on third-party disposable reducing instruments utilized in every process, establishing a recurring income stream linked to surgical procedures. Moreover, Professional-Dex holds 2.2 million contingent worth rights (CVRs) associated to Zimmer Biomet’s acquisition of Monogram Applied sciences. These CVRs are carried at zero worth on the steadiness sheet however may yield over $25 million (roughly $6.80 per share) if future mBôs milestones are met.
The acquisition of Superior Precision Machining in February 2026 additional strengthens Professional-Dex by integrating a key provider, increasing manufacturing capability, and including higher-margin prospects within the aerospace, protection, and authorities sectors. At its present valuation, Professional-Dex is taken into account to supply uneven upside potential. The corporate is valued totally on its steady core enterprise, whereas the potential economics from the mBôs platform and the off-balance-sheet CVR worth are factored in at little to no price. If commercialization of the mBôs platform scales successfully over the following 24 to 36 months, Professional-Dex is positioned for a major improve in earnings energy and a considerably larger share value.
